Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling

Zhun Xiao; Qiang Ji; Yadong Fu; Siqi Gao; Yonghong Hu; Wei Liu; Gao‐Feng Chen; Yongping Mu; Jiamei Chen; Ping Liu

doi:10.1007/s11655-021-3304-y

ScienceGate Book Chapters

JOURNAL ARTICLE

Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling

Zhun Xiao Qiang Ji Yadong Fu Siqi Gao Yonghong Hu Wei Liu Gao‐Feng Chen Yongping Mu Jiamei Chen Ping Liu

Year: 2021 Journal: Chinese Journal of Integrative Medicine Vol: 29 (4)Pages: 316-324 Publisher: Springer Science+Business Media

DOI: 10.1007/s11655-021-3304-y

Get Full-Text PDF Get Analytical Report

Keywords:

Amygdalin Sirius Red SMAD Fibrosis Hepatic stellate cell Chemistry Endocrinology In vivo Hydroxyproline Internal medicine Carbon tetrachloride CCL4 Hepatic fibrosis Medicine Transforming growth factor Pharmacology Pathology Biology

Metrics

Cited By

1.30

FWCI (Field Weighted Citation Impact)

Refs

0.77

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Liver physiology and pathology

Health Sciences → Medicine → Hepatology

Drug-Induced Hepatotoxicity and Protection

Life Sciences → Pharmacology, Toxicology and Pharmaceutics → Pharmacology

Liver Disease and Transplantation

Health Sciences → Medicine → Hepatology

Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling

Metrics

Citation History

Topics

Related Documents

SIRT1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the TGF-β/smad signaling pathway

GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway

Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway

Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway

Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation